Cargando…
Type III collagen metabolism in soft tissue sarcomas.
Sera of 85 patients with benign soft tissue lesions or sarcomas of soft tissues were investigated for a collagen metabolite, the aminoterminal propeptide of type III procollagen (PIIINP). Patients were divided into three groups: benign soft tissue lesions (n = 39), localised (n = 29) and metastatic...
Autores principales: | Wiklund, T. A., Elomaa, I., Blomqvist, C. P., Risteli, L., Risteli, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977732/ https://www.ncbi.nlm.nih.gov/pubmed/1739616 |
Ejemplares similares
-
Type I and type III collagen metabolites in adult osteosarcoma patients.
por: Wiklund, T., et al.
Publicado: (1996) -
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.
por: Blomqvist, C., et al.
Publicado: (1996) -
Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.
por: Elomaa, I., et al.
Publicado: (1992) -
Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients.
por: Saarto, T., et al.
Publicado: (1998) -
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.
por: Kylmälä, T., et al.
Publicado: (1995)